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Abstract 
The European sea bass (Dicentrarchus labrax) is an important farmed fish species in the Mediterranean area, very 
sensitive to the infection by encephalopathy and retinopathy virus (VERv), or Betanodavirus, which causes massive 
mortalities. Effective vaccines to fight the pathology are not yet available and in this work we describe a promising 
intraperitoneal immunization route against VERv of sea bass juveniles. We performed intraperitoneal and immersion 
immunization trials with a VERv (isolate 283.2009 RGNNV) inactivated by formalin, β‑propiolactone and heat treat‑
ment. Interestingly, the intraperitoneal immunization with formalin‑inactivated VERv induced a significant antigen‑
specific IgM production, differently from other inactivation protocols. However, the same formalin‑inactivated antigen 
resulted in very low IgM antibodies when administered by immersion. Following the intraperitoneal injection with 
formalin‑inactivated virus, the quantitative expression of the antiviral MxA gene showed a modulation of transcripts 
in the gut after 48 h and on head kidney after 24 h, whereas ISG12 gene was significantly up‑regulated after 48 h 
on both tissues. In immersion immunization with formalin‑inactivated VERv, a modulation of MxA and ISG12 genes 
after 24 h post‑treatment was detected in the gills. An effective uptake of VERv particles in the gills was confirmed by 
immunohistochemistry using anti‑VERv antibodies. Lastly, in challenge experiments using live VERv after intraperito‑
neal immunization with formalin‑inactivated VERv, we observed a significant increase (81.9%) in relative survival per‑
centage with respect to non‑immunized fish, whereas immersion immunization resulted in no protection. Our results 
suggest that intraperitoneal immunization with formalin‑inactivated VERv could be a safe and effective strategy to 
fight Betanodavirus infection in European sea bass.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Viral encephalopathy and retinopathy (VER), also known 
as viral nervous necrosis (VNN), is a severe infectious 
disease characterized by neuropathological changes and 
associated with high mortality in several fish species.
Viruses belonging to the Nodaviridae family, genus 
Betanodavirus, are non-enveloped single strand positive 
RNA virus characterized by an extremely high resistance 
to chemical and physical agents [1]. Betanodavirus is a 
highly pathogenic virus able to evade the host’s protective 
systems and can either replicate and transmit progeny to 
other cells or remain in a latent condition [2]. Betano-
davirus is one of the most significant viral pathogens of 
finfish and represents a bottleneck for development of 
mariculture in several countries [3, 4].
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Several experimental vaccines against VNN have been 
tested so far [5–7]. However, most of them have been 
tested on grouper (Epinephelus spp.), very likely the most 
important and valuable fish amongst the VER-suscepti-
ble species [8]. An inactivated VERv vaccine (RGNNV 
genotype) against VER of sevenband grouper (Epinephe-
lus septemfasciatus) has been produced and marketed 
in Japan. Sea bass (Dicentrarchus labrax) is the second 
most farmed species in the Mediterranean Sea (FEAP 
2005–2014) and also highly susceptible to VER. Notably, 
the VER introduction in the Mediterranean basin dates 
back to the early 90s and was firstly detected in sea bass 
hatcheries [9]. All stages of sea bass are highly sensitive to 
Betanodavirus but mortality can vary depending on the 
fish age and water temperature [10]. Larval and juvenile 
stages are commonly the most affected, reaching mortali-
ties up to 100%. Infected larvae and juvenile stages often 
show flexing of the body, muscle tremors and abnormal 
swimming behaviour, which includes vertical position-
ing and spinning resulting from traumatic lesions [11]. 
Betanodavirus also causes hyperinflation of the swim 
bladder, with diseased fish present primarily at the sur-
face. In adults, where the mortaly rate can reach 50–60% 
[10, 12], the most common clinical sign is abnormal 
swimming.
Despite the huge losses to Mediterranean aquaculture, 
in particular to sea bass farms, very few vaccines have 
been tested in this species. Only few experimental prod-
ucts based on recombinant protein or synthetic peptides 
have been used by injecting intramuscularly juveniles sea 
bass of 20–66 g [13, 14]. The use of a recombinant cap-
sid protein has given interesting results but, at present, a 
vaccine against Betanodavirus for D. labrax is commer-
cially not available.
The objectives of the present work were: (1) to inves-
tigate the best inactivation system for the production of 
immunogens, (2) to test the efficacy of the best inactiva-
tion method to protect experimentally, infected fish, and 
(3) to evaluate the immune response of immunized Euro-
pean sea bass. To achieve this we used two size-classes 
of fish, on the base of previous studies from our labora-
tory showing that intraperitoneal injection is inadvisable 
in fish with a mean weight lower than 5 g, and that bath 
challenge is not applicable over that weight.
Materials and methods
Fish
Eight hundred and twenty (820) juvenile European sea 
bass (410 with an average weight of 2.10 ± 0.25 g and 410 
with an average weight of 6.30 ± 0.45 g) were transferred 
from a VER-free commercial farm (previously tested by 
PCR to be VERv-free, data not shown) to the experimen-
tal aquarium at the Istituto Zooprofilattico Sperimentale 
delle Venezie (IZSVe, Legnaro-PD, Italy). On arrival, forty 
fish were sampled in order to be checked for the most 
common pathogens (parasites, bacteria and viruses). 
Preliminary analyses confirmed that all the fish were 
pathogen-free. After this first phase, they were equally 
distributed in 9 different close system tanks according to 
their size (4 tanks with 80 fish of bigger size, and 5 tanks 
with 80 fish of smaller size), with 300 L of artificial salt 
water at 25‰ of salinity, at a temperature of 22 ± 1  °C, 
oxygen 6 ± 0.5 ppm and artificial photoperiod of 8 h of 
light and 16 h of darkness.
Virus
The virus was selected according to its degree of high 
pathogenicity for fish. In 2009, RGNNV 283.2009 was 
isolated from severely affected sea bass during an out-
break in a commercial farm in the northern Adriatic Sea. 
The virus had been previously used in the IZSVe experi-
mental aquarium, showing a mortality rate of  >35% by 
immersion exposure in sea bass [15, 16]. The isolate was 
propagated on E-11 cells (10 passages) [17], a clone of 
SSN-1 cell line [18], in 150 cm2 tissue culture flasks using 
L-15 medium (Leibovitz) (Sigma-Aldrich) without fetal 
calf serum. The collected virus was subjected to titra-
tion by endpoint dilutions assays. Titres were calculated 
according to the Spearman–Karber formula [19] and 
expressed as TCID50/mL.
Immunogens preparation
The E-11 cell medium containing VERv was centrifuged 
at 2000 g for 10 min to remove cell debris, and then, the 
virus was inactivated with three different methods to 
prepare three different immunogens (titre 6.31 × 107 
TCID50/mL). Formalin inactivation was carried out by 
adding buffered formalin (Carlo Erba, Italy) at a final 
concentration of 10 µL/mL and left at room temperature 
(22–25 °C) for 1 week. The β-propiolactone (BPL, Ferak, 
Berlin) inactivation was performed by adding 20 µL/mL 
of BPL for 3  h at 37  °C. Inactivation by heat treatment 
was done in a heated bath at 70  °C for 1  h. All immu-
nogen preparations were checked after treatment using 
virological analyses according to a standard procedure 
[16], performing three sequential serial blind passages to 
ensure the complete inactivation of the pathogen. One 
batch of virus was kept untreated and used for a live virus 
immersion trial.
Fish immunization and challenge
After a period of acclimation of 10  days, fish were 
immunized as follows. Bigger fish (average weight 
of 6.30  ±  0.45  g) were sedated with 10  mg/L tricaine 
methasulfonate (MS-222) (Sigma-Aldrich) and then 
immunized by intraperitoneal injection (i.p.) of 0.1 mL/
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fish (using syringes with a 26-gauge needle) of the three 
different immunogens preparations described above 
(one per tank); whereas smaller fish (average weight of 
2.10 ± 0.25 g) were immunized by immersion in a 30-L 
water tank with aerator for 2  min with a final titre of 
106 TCID50/mL of the same inactivated formulations. 
A new group was added and immersed with a sub-
optimal dose of live virus (approximately 104 TCID50/
mL), following a previous protocol [20]. The controls 
for experimental groups were done by i.p. injection 
and immersion (mock-immunization) with 0.01 M PBS 
(Sigma-Aldrich). These controls acted as negative con-
trol for immunological assays and as positive control 
in the challenge. One tank was left untreated as nega-
tive control, in order to assess general viability during 
treatments and challenge. Thirty days post immuniza-
tion, blood and brain samples were collected from fish 
(n = 10) from all groups.
According to the results from immunological analyses 
(see below), we focused our study on formalin-inacti-
vated VERv groups, from which we performed real-time 
quantitative PCR (qPCR) to measure the transcription 
of antiviral genes. We then tested the survival rate in the 
same groups after challenge with live virus.
After 30  days post immunization (dpv), the for-
mylated groups were challenged with RGNNV 283.2009 
by immersion or intramuscular injection, according to 
the prior immunization route. As for immersion, each 
group of 50 fish was transferred to a 30-L water tank 
with aerator and infected for 4  h by adding 30  mL of 
virus solution (final titre 106 TCID50/mL) to the water. 
For intramuscular injection, 50 fish were injected (after 
anesthesia) with 0.1  mL of virus solution (approxi-
mately 6.31 106 TCID50/fish). The “positive control” 
group, mock-immunized by i.p. and immersion respec-
tively by using PBS 0.01 M, was infected by immersion 
or injected as explained before. The “negative control” 
group was either mock infected by immersion by adding 
minimum essential medium (MEM-10) without virus to 
the water, or injected with 0.1 MEM-10 rather than with 
the virus solution administered to the intramuscularly 
infected group.
Fish were then transferred back to the original 
tanks and kept at a temperature of 25  ±  1  °C, oxygen 
6 ± 0.5 ppm and artificial photoperiod of 8 h of light and 
16 h of darkness. Fish were checked twice a day and the 
dead ones were removed. Brain samples were collected 
individually from each dead fish and stored at −80  °C. 
The experiment ended on day 30 and the relative per-
cent survival (RPS) calculated. All the remaining fish 
were euthanized by an overdose of MS-222, sampled and 
stored at −80 °C until analyses.
Immunological analyses
The blood from juveniles sea bass was collected from the 
caudal vein of lethally anaesthetized fish (overdose of 
MS-222). Sera were obtained by centrifugation at 1000 g 
for 5 min.
Indirect ELISA
VERv-specific IgM detection was performed using a pre-
viously developed Indirect ELISA [20]. The ELISA assays 
data are presented as the mean absorbance  ±  SD. Ten 
single samples by group were measured in duplicate wells 
and optical density values (OD 450 nm) of control wells 
were automatically subtracted from samples values.
Serum neutralization tests
Serial twofold dilutions (1:20–1:2560) of heat inactivated 
serum were prepared in a 96 well plate (Corning) with 
MEM Leibovitz medium without FBS. Diluted sera were 
incubated with a defined amount of infectious virus (100 
TCID50/50 µL), 4 wells were used for each sample. After 
incubation overnight at +4  °C, the virus-serum mixture 
was added to a confluent E-11 cell line and incubated for 
10  days at 25  °C. Plates were observed every 3  days for 
appearance of cytopathic effects (CPE). The neutraliza-
tion value of a virus is defined as the reciprocal of the 
highest dilution of serum that completely inhibits CPE.
Real‑time quantitative PCR
At 0, 24 and 48 h post immersion with formylated virus, 
4 pools of 5 gill archs per time points per group were col-
lected, whereas after i.p. immunization with formylated 
virus, 3 single samples of head kidney and gut were col-
lected per time points and per group. Three muscle 
samples from control groups were sampled behind the 
pectoral fin. Samples were immediately placed in 1 mL of 
denaturing solution (Tripure, Roche), total RNA was iso-
lated following the manufacturer’s instructions and sub-
sequently suspended in DEPC-treated water. For reverse 
transcription, the BioScript RNase H minus (Bioline) 
enzyme was used following the manufacturer’s instruc-
tions. The absence of DNA contamination was checked 
using sea bass β-actin primers that bracketed an intron 
[20]. The transcripts relative to MxA and ISG12 genes 
were determined with an Mx3000P™ Real-time quanti-
tative PCR system (Stratagene) equipped with version 
2.02 software, using the Brilliant SYBR Green Q-PCR 
Master Mix (Stratagene) following the manufacturer’s 
instructions. ROX was used as internal passive reference 
dye. Specific PCR primers (Table  1) were designed for 
the amplification of products (ca. 200 bp) from the con-
served region of all the analyzed genes and ribosomal 18S 
rRNA was used as house-keeping gene. A 10 ng of cDNA 
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template was used in each PCR reaction. PCR conditions 
were as follows: 95 °C for 10 min, followed by 35 cycles of 
95 °C for 45 s, 52 °C for 45 s and 72 °C for 45 s. Reactions 
were performed in triplicate for each template cDNA, 
which was replaced with water in all blank control reac-
tions. Each run was terminated with a melting curve 
analysis, which resulted in a melting peak profile specific 
to the amplified target DNA. The analysis was carried 
out using the endpoint method option of the Mx3000P™ 
software, allowing the fluorescence data to be collected at 
the end of each extension stage of amplification. A rela-
tive quantification was performed by comparing the lev-
els of the target transcript to the reference transcript (18S 
rRNA). Quantitative assessment was based on the deter-
mination of the threshold cycle (Ct), defined as the cycle 
at which a statistically significant increase in fluorescence 
above the background signal was detected using the 
ΔΔCt method. The calibrator, defined as 1.0 value, was 
the average of 3 muscle samples from control fish due to 
the low expression of these antiviral genes in the muscle.
Virological analysis
Virus isolation in cell culture
Samples (cell culture supernatant and fish brains) were 
examined by previously described standard virological 
techniques [16].
Real Time RT-PCR analyses for detection of Betano-
davirus RNA2 were performed using a slightly modi-
fied version of the published protocol [21]. Briefly, total 
RNA was extracted from 100 µL of the sample using the 
NucleoSpin® RNA kit (Macherey-Nagel) and according 
to the manufacturer’s instructions. Real Time RT-PCR 
was conducted with RotorGene Q (Qiagen), Rotor Gene 
6000 (Corbett, Australia) using the OneStep RT-PCR 
Kit (Qiagen) following the manufacturer’s recommenda-
tions, adding Random primers (Applied Biosystems) and 
RNase Inhibitor (Promega). Primers and probe were used 
at a final concentration of 0.9 and 0.75 µM, respectively, 
random primers at concentration 1X, RNase Inhibitor 
at final concentration of 8 U/µL and thermal cycling was 
performed at 50 °C for 30 min and denaturation at 95 °C 
for 10 min followed by 45 cycles of 95 °C for 10 s, 54 °C 
for 35 s and 72 °C for 1 s, with a final incubation at 40 °C 
for 30  s. Data analyses were performed with the Rotor 
Gene 6000/RotorGene Q series software.
Immunohistochemistry
For IHC, gills from sea bass immersed with formalin-
inactivated VERv were sampled at 48 h post-immersion 
(1  min). Gills were fixed in ice-cold Bouin’s fixative for 
7  h in Bouin’s at 4  °C. After embedding in paraplast, 
blocks were serially sectioned at a thickness of 7 μm as 
previously described [22]. The immunohistochemical 
reaction was performed by ABC-peroxidase with nickel 
enhancement, as previously described [23]. Serial sec-
tions were incubated with the mAb 4C3 [24] (that rec-
ognizes VERv capsid protein) diluted 1:10 in PBS 0.1 M 
(Sigma-Aldrich), pH 7.3 containing 5% normal horse 
serum and 0.1% sodium azide, or with pAb 283 [25] 
(that recognizes the whole virus) diluted 1:3000 using 
PBS containing 5% normal goat serum and 0.1% sodium 
azide. Controls were carried out by omitting the pri-
mary antibody. Thereafter, sections were incubated for 
60 min with biotinylated horse anti-mouse or anti rabbit 
IgG sera (Vector Labs., Burlingame, USA) diluted 1:1000 
with PBS containing 0.1% sodium azide and 1% BSA, fol-
lowed by incubation for 60 min with avidin-biotinylated 
peroxidase complex (ABC, Vectastain Elite, Vector). Fol-
lowing rinses and staining (diaminobenzidine and nickel 
enhancement), sections were dehydrated, mounted and 
examined under a Zeiss microscope equipped with a col-
our video camera (Axio Cam MRC, Arese, Milano, Italy) 
and a software package (KS 300 and AxioVision).
Statistical analysis
The number of fish per experimental group was calcu-
lated according to the expected mortality rate (35%) and 
0.05 as α error (one-side) and power 80% (1 − β = 0.80). 
Each fish in the study was followed over time and the 
event “death” was recorded and verified by Real Time 
RT-PCR.
The Kaplan–Meier method was used to estimate the 
survival function from lifetime data, which allowed to 
draw the survival curve for each group as a step curve 
and to measure the length of time the fish would survive 
the infection. In the graph, the y-axis plot indicates the 
cumulative probability of the surviving fish at each time 
[26]. To compare the different survival curves, the non-
parametric Wilcoxon–Breslow–Gehan test was used for 
equality of survivor functions. One-sided tests with a 
p < 0.05 were considered as significant. Statistical analy-
ses for potency test were performed using the STATA 
12.1 software.
Statistical analysis for immunological parameters was 
performed by Graph Pad Prism 6.0 software statistical 
Table 1 Specific Real-time quantitative PCR primers
Gene Primer sequence EMBL accession
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package. The data from two differents experiments are 
presented as the mean ± SD of four pools of five organs 
in the gills and three single samples in the head kidney 
and gut in Real-time quantitative PCR and ten single 
samples for Indirect ELISA. The statistical significance 
among groups for qPCR and Indirect ELISA was deter-
mined using One-way ANOVA followed by Bonferroni’s 
multiple comparison test and the level for accepted sta-
tistical significance was p < 0.05.
Results
Virological analysis
All three inactivation methods proved to inactivate 
Betanodavirus completely, with no viral growth in cell 
culture after 3 blind passages. The immunogens were 
then suitable to be used for experimental trials on 
animals.
No mortality was observed in fish both during and 
after immunization in all the treated groups. Thirty days 
post immunization, brains from immunized fish were 
collected and checked for VERv positivity by Real Time 
RT-PCR and virological analysis.
Positivity was found only in the live virus immersion 
immunized group (average ct 20.88 ± 4.29), whereas all 
the others gave negative results.
Immunological analyses
Anti-VERv specific IgM was detected by Indirect ELISA 
in serum samples after immersion and intraperitoneal 
immunization with the virus inactivated by different 
ways.
In all the samples injected intraperitoneally the pres-
ence of anti-VERv specific antibodies was detected (Fig-
ure  1). Fish immunized with formalin-inactivated VERv 
presented a high specific IgM production (OD 450  nm 
of ca. 0.627  ±  0.08) with respect to the control group; 
as well, fish immunized with BPL-inactivated VERv pre-
sented a high specific IgM production (OD 450  nm of 
ca. 0.540  ±  0.12), although a high standard deviation 
was observed in the latter case. Moreover, fish immu-
nized with temperature-inactivated VERv presented a 
high standard deviation; some samples produced a high 
level of specific IgM while a lower but detectable IgM 
level was observed in another subjects (OD 450 nm of ca. 
0.340 ± 0.272).
Indirect ELISA results referring to sea bass immersed 
in different preparations are also shown in Figure  1, 
where those exposed to a sub-optimal dose of live virus 
presented a quantity of specific IgM (OD 450 nm of ca. 
0.445  ±  0.1) higher than that found in the formalin-
inactivated VERv group, which has a lower antibody 
production. Temperature-inactivated VERv and BPL-
inactivated VERv immunized groups both presented a 
higher standard deviation compared with the formalin-
inactivated one due to the uneven responses among 
examined samples. As negative controls, samples from 
mock-immunized fish (intraperitoneally and by immer-
sion) showed no detectable IgM antibody, as expected.
The serum neutralization test showed neutralizing 
antibodies against RGNNV 283.2009 only in the forma-
lin-inactivated VERv i.p. immunized group (average titre 
GMT 3.8 ± 2.2), whereas all the others showed negative 
results (data not shown).
Quantitative-PCR, after immersion and intraperi-
toneal immunization with formalin-inactivated VERv, 
was performed to analyze the expression of antiviral 
immune response genes in the gills, head kidney and 
gut. Transcripts levels of MxA and ISG12 genes in gills 
after immersion are shown in Figure 2. Results are repre-
sented as a scatter plot of pooled samples, with each dot 
as a pool of 5 samples at 24 and 48  h after immersion, 
using muscle as calibrator and comparing the expression 
with mock-immunized control. A significant modulation 
of MxA gene (p < 0.05) was observed at 24 h (Figure 2), 
as well as an increase at the same time for ISG12 gene 
(Figure 2), although not statistically significant due to the 
high individual variability.
The expression of genes encoding for relevant anti-
viral genes in head kidney and gut after intraperitoneal 
immunization with formalin-inactivated VERv is shown 
in Figure  3 as a scatter plot of individual samples, with 
each dot representing single samples at 24 and 48 h after 
injection, and compared to the expression in control fish. 
Regarding the interferon-inducible MxA gene, a signifi-
cant upregulation of MxA gene (p < 0.05) was observed 
at 48 h in the gut (Figure 3A), whereas in head kidney a 
not meaningful mean increase tendency was observed 
at 24  h (Figure  3C). A significant modulation of ISG12 
gene (p < 0.05) was observed at 48 h in head kidney (Fig-
ure  3D), while in the gut a significant increase at 48  h 
(Figure 3B) and at 24 h (Figure 3D) was registered.
Immunohistochemistry
Formalin-inactivated VERv was detected in the gills of 
sea bass at 48 h post-immersion by employing IHC. In 
particular, the mAb 4C3 (Figure  4A) recognised scat-
tered cells, with a strong positive signal, distributed in 
the gill filaments and parallel secondary lamellae. In addi-
tion a weak reaction was homogeneously detected in the 
gill mucosal tissue. Notably, the control specimens (no 
immersion immunized animals) did not evidence any 
mAb 4C3 staining (Figure 4B). Differently, in immersion 
fish the pAb 283 (Figures 4C and D) confirmed the pres-
ence of inactivated VERv in the sea bass gills 48 h after 
the immersion, showing a strong reaction in the thin epi-
thelium covering the secondary lamellae and in the basal 
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cells localized between the secondary lamellae on gill fila-
ments. No reaction was found in control sections without 
primary antibody (Figure 4E).
Vaccine potency
The challenge was performed only on formylated groups 
(i.p. and immersion immunized), as described above. 
Figure 1 Detection of VERv-specific IgM after immersion and intraperitoneal immunization with Betanodavirus inactivated by differ-
ent methods. Dilutions 1/60 of sera from different groups collected 30 days postimmunization were tested by Indirect ELISA using as antigen 106 
TCID50 per well of viral preparation and Pab IgM (diluted 1:10000). Background values (no viral preparation added) were automatically subtracted 
from OD 450 nm values of samples.
Figure 2 Real-time quantitative PCR. The expression level of genes coding for MxA and ISG12 in gills are shown in control fish (CTR Group) and 
in immersed immunized fish (VERv Group) at 24 and 48 h post immersion with formalin‑inactivated virus. The quantitative PCR amplification was 
performed in PCR arrays, and each point represents the mean ± SD of four diverse pools with 5 fish each.
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Cumulative mortality was of 12% in the i.p. immunized 
group and of 64% (Figure  5A) in the positive controls, 
with significant differences between groups (p  <  0.001). 
The RPS of the i.p. immunized group was 81.9%. On the 
other hand, immersion immunized fish showed a cumu-
lative mortality of 50%, whereas in the positive control 
group it turned out to be of 52% (Figure 5B), with no dif-
ferences between groups (p > 0.05) and a RPS of 1.6%.
Discussion
Betanodavirus infection is characterized by a high patho-
genicity and is associated with extensive mortality in fish 
farms [27]. Different attempts for immunization had pre-
viously been tested by inactivating the virus with either 
formalin [5, 28, 29] or binary ethylenimine (BEI) [28, 30], 
by the use of recombinant capsid proteins [31–33] or by 
DNA-based vaccines [33, 34]. Although some protection 
was obtained in sea bass fry by intramuscularly injecting 
a recombinant protein or synthetic peptides [13, 14], no 
vaccines are presently available to be used in D. Labrax 
(Additional file 1). In our study we tested different inac-
tivation methods for Betanodavirus, namely by using 
formylation, BPL and temperature, with the aim of pro-
ducing an effective antigen.
The inactivated antigen was then administered to fish 
through systemic (intraperitoneal) or mucosal (immer-
sion) routes and serological results showed that formyla-
tion was the best inactivation way for the production 
of specific and neutralizing serum IgM after i.p. immu-
nization. On the other hand, fish immunized i.p. with 
BPL and temperature-inactivated virus also showed the 
presence of specific serum IgM, but the high variability 
among individuals resulted in a poor statistical signifi-
cance of data. This latter observation could be explained 
by assuming that the inactivation method may result in 
a loss of antigenicity, which in turn results in a decrease 
Figure 3 Real-time quantitative PCR. The expression level of genes coding for MxA and ISG12 in gut and head kidney samples are shown in 
control fish (CTR Group) and in fish immunized intraperitoneally with formalin‑inactivated virus (VERv Group) at 24 and 48 h post immunization. The 
quantitative PCR amplification was performed in PCR arrays, and each point represents the mean ± SD of three single samples.
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of efficient antigenic sites and, correspondingly, to the 
measured high standard variation in heat and BPL group. 
Indeed, several attempts were performed to decrease the 
concentration or the treatment time with formalin, BPL 
and temperature, all unsuccessful (data not shown) due 
to the resistance of Betanodavirus to chemical and physi-
cal inactivation [28, 35–38]. However, the inactivation 
protocols we suggested and reported in this work were 
able to completely inactivate the VERv.
The effectiveness of immunization with formalin-inac-
tivated Betanodavirus administered i.p. was previously 
tested in other fish species. A significant specific anti-
body titer was measured in groupers (E. septemfasciatus) 
together with protection after challenge with live virus 
[5, 28]. Also, a single injection of formalin-inactivated 
Betanodavirus (RGNNV genotype) induced a humoral 
response and protection in Asian sea bass [29]. These 
data suggest that formylation can be a useful protocol for 
antigen preparation.
After having confirmed the presence of a humoral 
response induced by i.p. administration in sea bass, we 
examined the effects on the transcription of genes cod-
ing for antiviral responses. Interferon exerts its biologi-
cal functions mainly through the downstream activation 
of Mx and ISG genes [39–42], which are both interferon-
inducible and known to play an active-role in antiviral 
immune responses [43, 44]. Mx proteins are key play-
ers of antiviral responses, triggered by interferon type I 
(IFN-I) in response to viral infections and have been con-
sidered the main factor in determining the resistance of 
Figure 4 Immunoreactive uptake in gills of formalin-inactivated VERv immersed sea bass with mAb 4C3 (A, B) and pAb 283 (C, D, 
E). A Gill epithelium showing the presence of immunoreactivity employing mAb 4C3 (arrow). Scale bar = 10 μm. B Negative control showing the 
absence of immunoreactivity in gill tissue with mAb 4C3. Scale bar = 10 μm. C Gill epithelium showing the presence of immunoreactivity using 
pAb 283. Scale bar = 50 μm. D Higher magnification of immunoreactivity with pAb 283 (arrow). Scale bar = 20 μm. E Negative control showing the 
absence of immunoreactivity in gill tissue with pAb 283. Scale bar = 50 μm. F: filament, L: lamella.
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fish species to nodavirus infections. Consequently, Mx 
gene transcription can be used as an IFN-I system stim-
ulation reporter [45]. Two different Mx genes had been 
identified in European sea bass, proving that the isoform 
MxA is particularly modulated in nodavirus-infected sea 
bass [20, 46]. As previously shown [47], the ISG12 gene 
can also be employed in sea bass as a marker of antivi-
ral activities, since this ISG isoform is well expressed in 
gills [22], and significant ISG12 gene modulation can be 
induced in sea bass after in vitro stimulation with virus-
mimicking substance poly I:C [47].
Our results showed that both MxA and ISG12 genes 
were significantly upregulated in head kidney and gut, 
thus indicating an effect of the formylated antigenic 
preparation. Based on promising serological and molec-
ular results, we tested the efficacy of the immunization 
with formylated antigen given i.p. by challenging fish 
with live virus (RGNNV 283.2009). The results showed 
a high protection rate (81.9%) and, therefore, a single 
dose of i.p.-injected, formalin-inactivated RGNNV can 
be considered sufficient to elicit an in vivo protection of 
sea bass. The potential of our formalin-inactivated viral 
preparation as an effective immunogen was confirmed 
by: (1) a measurable humoral response; (2) a modulation 
in the expression of antiviral genes; (3) a seroconversion 
assay positivity; (4) a high protection after viral challenge.
Early life stages of D. labrax are the preferred target 
of Betanodavirus, reaching a mortality of 100% [35, 48] 
and in light of this we also investigated the possibility 
of immunizing sea bass at a young age through mucosal 
routes, namely by immersion. The efficacy of immersion 
immunization in eliciting humoral and cell-mediated 
immune responses has already been described is other 
fish species [49, 50]. Other interesting approaches have 
been explored by using inactivated VERv in immersion 
immunization, i.e. by employing nano-encapsulated for-
malin-inactivated or BEI-inactivated Betanodavirus prep-
arations for the protection of grouper larvae (Epinephelus 
coioides) from NNV disease [28].
After analyzing by ELISA the results from immersion 
immunization with formylated nodavirus, we observed 
the presence of very low but still detectable specific 
serum IgM, which suggests that a single immersion may 
induce a weak humoral response in sea bass. The use of 
antigens encapsulated in nanoparticles could be useful 
to improve the delivery and the uptake also in sea bass, 
but this assumption needs further investigation. Fur-
thermore, also the experimental groups immunized with 
BPL- and temperature-inactivated virus showed a scat-
tered presence of specific serum IgM, resulting in a high 
individual variability and poor statistical significance of 
data, again attributable to a possible loss of antigenicity.
Being the gills directly involved in antigen uptake during 
immersion immunization, we analyzed the transcription 
of MxA and ISG12 genes at 24 and 48 h post immersion 
with formylated antigen, and we observed a significantly 
upregulation of these genes at 24 h, likely suggesting a 
possible antiviral response in the tissue. Following immer-
sion immunization, the Mx and ISG12 transcription 
resulted much higher in the gills than in the kidney or gut 
after i.p. immunization. We can speculate that this differ-
ence could be due to the route of antigen uptake, because 
gills are in direct contact with the environment and 
must be armed with immune defences for the protection 
against pathogens [51]. Importantly, the presence of viral 
particles was demonstrated by IHC in the gill epithelium 
by using antibodies against the virus capsid protein (mAb 
4C3) and against the whole virus (pAb 283) [25].
It should be noted that the infection with sub-opti-
mal doses of live virus by immersion induced an effect, 
Figure 5 Cumulative survival rate of challenged sea bass previously immunized either by intraperitoneal injection or by immersion 
with formalin-inactivated VERv. Control group: fish mock‑immunized intraperitoneally or by immersion with PBS 0.01 M; Immunized group: fish 
immunized (A) intraperitoneally or (B) by immersion with formalin‑inactivated VERv; dpi: days post infection.
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measured by the presence of significant antibody levels 
after 30 days (Figure 1) [15, 20], and this could raise the 
possibility of vaccinating fish with a live/attenuated virus, 
as already shown in a grouper species (E. septemfascia-
tus) [52, 53]. However, the use of live pathogens for fish 
immunization raises concerns about their containment 
and poses risks of vertical/horizontal transmission [27]. 
To confirm these concerns, we observed by RT-PCR the 
presence of VERv in brain samples from all fish infected 
by sub-optimal doses of live virus (data not shown).
In summary, data obtained from immersion-immu-
nized fish, including the lack of protection in challenge 
trials, suggest that this way of administration needs to be 
further investigated also with studies including boosting/
adjuvants.
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